Literature DB >> 10421427

Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro.

M D Mediavilla1, S Cos, E J Sánchez-Barceló.   

Abstract

The aim of the present work was to study whether melatonin, at physiological concentrations, exerts its antiproliferative effects on MCF-7 human breast cancer cells by inducing the expression of some of the proteins involved in the control of the cell cycle. MCF-7 cells were cultured for 48 h in DMEM media containing either melatonin (1 nM) or the diluent (0.001% ethanol). At this concentration, after 48 hours of incubation, melatonin reduced the number of viable cells in relation to controls. The decreased cell proliferation was coincident with a significant increase in the expression of p53 as well as p21WAF1 proteins. These results demonstrate that melatonin inhibits MCF-7 cell proliferation by inducing an arrest of cell cycle dependent on an increased expression of p21WAF1 protein, which is mediated by the p53 pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421427     DOI: 10.1016/s0024-3205(99)00262-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  36 in total

1.  Inhibitory effect of melatonin on the growth of H22 hepatocarcinoma cells by inducing apoptosis.

Authors:  Li Qin; Ximing Wang; Qiuhong Duan; Beibei Chen; Shanshu He
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

Review 2.  Melatonin: an inhibitor of breast cancer.

Authors:  Steven M Hill; Victoria P Belancio; Robert T Dauchy; Shulin Xiang; Samantha Brimer; Lulu Mao; Adam Hauch; Peter W Lundberg; Whitney Summers; Lin Yuan; Tripp Frasch; David E Blask
Journal:  Endocr Relat Cancer       Date:  2015-04-15       Impact factor: 5.678

Review 3.  Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies.

Authors:  Lara G Sigurdardottir; Unnur A Valdimarsdottir; Katja Fall; Jennifer R Rider; Steven W Lockley; Eva Schernhammer; Lorelei A Mucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-07       Impact factor: 4.254

4.  Melatonin and its derivatives counteract the ultraviolet B radiation-induced damage in human and porcine skin ex vivo.

Authors:  Cezary Skobowiat; Anna A Brożyna; Zorica Janjetovic; Saowanee Jeayeng; Allen S W Oak; Tae-Kang Kim; Uraiwan Panich; Russel J Reiter; Andrzej T Slominski
Journal:  J Pineal Res       Date:  2018-05-21       Impact factor: 13.007

Review 5.  Expression and putative functions of melatonin receptors in malignant cells and tissues.

Authors:  Cem Ekmekcioglu
Journal:  Wien Med Wochenschr       Date:  2014-07-15

6.  Melatonin and its metabolites ameliorate ultraviolet B-induced damage in human epidermal keratinocytes.

Authors:  Zorica Janjetovic; Zachary P Nahmias; Sherie Hanna; Stuart G Jarrett; Tae-Kang Kim; Russel J Reiter; Adrzej T Slominski
Journal:  J Pineal Res       Date:  2014-06-28       Impact factor: 13.007

7.  Pro-oxidant and antioxidant effects of N-acetylcysteine regulate doxorubicin-induced NF-kappa B activity in leukemic cells.

Authors:  Nnenna Adimora Finn; Melissa Lambeth Kemp
Journal:  Mol Biosyst       Date:  2011-12-01

Review 8.  Sleep and circadian disruption and incident breast cancer risk: An evidence-based and theoretical review.

Authors:  Laura B Samuelsson; Dana H Bovbjerg; Kathryn A Roecklein; Martica H Hall
Journal:  Neurosci Biobehav Rev       Date:  2017-10-13       Impact factor: 8.989

Review 9.  Novel non-calcemic secosteroids that are produced by human epidermal keratinocytes protect against solar radiation.

Authors:  Andrzej T Slominski; Zorica Janjetovic; Tae-Kang Kim; Piotr Wasilewski; Sofia Rosas; Sherie Hanna; Robert M Sayre; John C Dowdy; Wei Li; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2015-01-21       Impact factor: 4.292

Review 10.  Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Authors:  Sara Proietti; Alessandra Cucina; Russel J Reiter; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.